Article Type

1 - 15 of 186 Results       Clear All

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

Gladstone in the News October 14, 2020

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.

Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab

Refined Mapping of HIV’s Reservoir Could Aid in Cure Research

Gladstone in the News October 12, 2020

Refined Mapping of HIV’s Reservoir Could Aid in Cure Research

POZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.

Gladstone Experts HIV/AIDS Virology Roan Lab

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

Gladstone in the News October 8, 2020

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.

Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

Gladstone in the News October 6, 2020

Doudna Inc.: How Cal Scientist Created a Biotech Startup Engine

San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.

Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing

What We Know about Trump’s Extraordinary COVID-19 Treatment

Gladstone in the News October 5, 2020

What We Know about Trump’s Extraordinary COVID-19 Treatment

San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.

Gladstone Experts COVID-19 Virology Greene Lab

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

Gladstone in the News October 2, 2020

Next Wave of Bay Area Neuroscience Companies: What Are They Doing Now?

San Francisco Business Times—Gabaeron, founded by Gladstone President Emeritus Bob Mahley, MD, PhD, and Therini Bio (formerly Medared), founded upon work by Senior Investigator Katarina Akassoglou, PhD, are among Bay Area biotech companies focusing on neurological diseases that collectively raised more than $3 billion from venture capital firms and the public capital markets in 2020.

Gladstone Experts Multiple Sclerosis Neurological Disease Akassoglou Lab Mahley Lab

Genetic Network that Differentiates Regulatory T Cells Mapped

Gladstone in the News October 2, 2020

Genetic Network that Differentiates Regulatory T Cells Mapped

Clinical Omics—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains his lab's recent discovery of the the gene networks that distinguish regulatory T cells from other types of T cells, and the implication for therapies against cancer and autoimmune diseases.

Gladstone Experts Autoimmune Diseases Marson Lab

Immune System Gene Braking Discovery Opens Doors to New Cancer Therapies

Gladstone in the News October 1, 2020

Immune System Gene Braking Discovery Opens Doors to New Cancer Therapies

Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.

Gladstone Experts Autoimmune Diseases Genomic Immunology Marson Lab

‘Berlin Patient’ Dies at 54: Timothy Ray Brown, the First Man Cured of HIV, Succumbs to Leukemia

Gladstone in the News September 30, 2020

‘Berlin Patient’ Dies at 54: Timothy Ray Brown, the First Man Cured of HIV, Succumbs to Leukemia

San Francisco Chronicle—Warner Greene, MD, PhD, director of the Center for HIV Cure Research, explains how Timothy Ray Brown, who was cured of HIV/AIDS via a bone marrow transplant, changed the field of HIV research.

Gladstone Experts HIV/AIDS Center for HIV Cure Research Greene Lab

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Gladstone in the News September 27, 2020

CRISPR Screening Identifies Human Host Pathways That Facilitate Coronavirus Infection

Life Sciences—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene Editing

Some Covid-19 Patients Show Signs of Heart Damage Months Later

Gladstone in the News September 23, 2020

Some Covid-19 Patients Show Signs of Heart Damage Months Later

The Wall Street Journal—Senior Investigator Todd McDevitt, PHD, comments on the damage SARS-CoV-2 can inflict on heart cells, which he and Senior Investigator Bruce Conklin, MD, recently reported in an article deposited on bioRxiv.

Gladstone Experts COVID-19 Cardiovascular Disease Data Science and Biotechnology Conklin Lab McDevitt Lab

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media